
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19770436
[patent_doc_number] => 20250051862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS
[patent_app_type] => utility
[patent_app_number] => 18/566011
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566011 | METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS | Jun 1, 2022 | Pending |
Array
(
[id] => 18058375
[patent_doc_number] => 20220389461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => CRISPR EDITING IN DIPLOID GENOMES
[patent_app_type] => utility
[patent_app_number] => 17/752122
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752122 | CRISPR EDITING IN DIPLOID GENOMES | May 23, 2022 | Abandoned |
Array
(
[id] => 19962752
[patent_doc_number] => 12332245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Cancer biomarkers and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/664006
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 57
[patent_no_of_words] => 64789
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/664006 | Cancer biomarkers and methods of use thereof | May 17, 2022 | Issued |
Array
(
[id] => 17990465
[patent_doc_number] => 20220356502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR HARVESTING MAMMALIAN CELL CULTURES
[patent_app_type] => utility
[patent_app_number] => 17/746008
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746008 | Methods for harvesting mammalian cell cultures | May 16, 2022 | Issued |
Array
(
[id] => 19332827
[patent_doc_number] => 20240247257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => SYSTEM AND METHODS FOR INSERTION AND EDITING OF LARGE NUCLEIC ACID FRAGMENTS
[patent_app_type] => utility
[patent_app_number] => 18/561669
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561669 | SYSTEM AND METHODS FOR INSERTION AND EDITING OF LARGE NUCLEIC ACID FRAGMENTS | May 16, 2022 | Pending |
Array
(
[id] => 17830500
[patent_doc_number] => 20220267804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHODS FOR INCREASING THE RATE OF GENETIC PROGRESS AND GENERATING INBRED LINES IN NON-HUMAN MAMMALS
[patent_app_type] => utility
[patent_app_number] => 17/744457
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744457 | METHODS FOR INCREASING THE RATE OF GENETIC PROGRESS AND GENERATING INBRED LINES IN NON-HUMAN MAMMALS | May 12, 2022 | Pending |
Array
(
[id] => 20563571
[patent_doc_number] => 12566177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Antigen and antibodies prepared based on PADI4 serving as tumor marker, and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/662422
[patent_app_country] => US
[patent_app_date] => 2022-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 5405
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662422 | Antigen and antibodies prepared based on PADI4 serving as tumor marker, and application thereof | May 6, 2022 | Issued |
Array
(
[id] => 18056513
[patent_doc_number] => 20220387599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => OLIGONUCLEOTIDES WITH NUCLEOSIDE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/713025
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713025 | OLIGONUCLEOTIDES WITH NUCLEOSIDE ANALOGS | Apr 3, 2022 | Pending |
Array
(
[id] => 17766001
[patent_doc_number] => 20220239615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => RNA TARGETING METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/711924
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711924 | RNA targeting methods and compositions | Mar 31, 2022 | Issued |
Array
(
[id] => 17720718
[patent_doc_number] => 20220213438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => NUTRIENT COMPOSITIONS AND METHODS, KITS, AND CELL COMPOSITIONS FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/703782
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703782 | NUTRIENT COMPOSITIONS AND METHODS, KITS, AND CELL COMPOSITIONS FOR PRODUCING THE SAME | Mar 23, 2022 | Abandoned |
Array
(
[id] => 17685975
[patent_doc_number] => 20220193267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A
[patent_app_type] => utility
[patent_app_number] => 17/691648
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691648 | ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A | Mar 9, 2022 | Abandoned |
Array
(
[id] => 19491801
[patent_doc_number] => 12110498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
[patent_app_type] => utility
[patent_app_number] => 17/690429
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 35
[patent_no_of_words] => 37525
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690429 | Compositions and methods for genomic integration of nucleic acids into exogenous landing pads | Mar 8, 2022 | Issued |
Array
(
[id] => 20159300
[patent_doc_number] => 12385921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Methods for the diagnosis and treatment of gastrointestinal stromal tumors
[patent_app_type] => utility
[patent_app_number] => 17/688190
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 9299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688190 | Methods for the diagnosis and treatment of gastrointestinal stromal tumors | Mar 6, 2022 | Issued |
Array
(
[id] => 18057976
[patent_doc_number] => 20220389062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/681479
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681479 | NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS | Feb 24, 2022 | Pending |
Array
(
[id] => 17913600
[patent_doc_number] => 20220315995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => THIOL-CONTAINING CLEAVE REAGENTS AND OXIDATIVE WASH
[patent_app_type] => utility
[patent_app_number] => 17/592189
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592189 | THIOL-CONTAINING CLEAVE REAGENTS AND OXIDATIVE WASH | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17611945
[patent_doc_number] => 20220154224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE)
[patent_app_type] => utility
[patent_app_number] => 17/649308
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649308 | Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste) | Jan 27, 2022 | Issued |
Array
(
[id] => 17704560
[patent_doc_number] => 20220204566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/565796
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565796 | ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES | Dec 29, 2021 | Pending |
Array
(
[id] => 17930185
[patent_doc_number] => 20220325310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST
[patent_app_type] => utility
[patent_app_number] => 17/558181
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558181
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558181 | NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17929780
[patent_doc_number] => 20220324905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => ENHANCED PROTEIN PURIFICATION THROUGH A MODIFIED PROTEIN A ELUTION
[patent_app_type] => utility
[patent_app_number] => 17/558406
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558406 | ENHANCED PROTEIN PURIFICATION THROUGH A MODIFIED PROTEIN A ELUTION | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17520528
[patent_doc_number] => 20220106377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR GENE ASSEMBLY
[patent_app_type] => utility
[patent_app_number] => 17/554013
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554013 | Compositions and methods for T-cell receptor gene assembly | Dec 16, 2021 | Issued |